2026 MIPS Improvement Activity IA_BE_25: Drug Cost Transparency

Written by Tucker Deyett, Dedicated Advisor, ReportingMD. Source data: CMS Quality Payment Program 2026 measure specifications and benchmark files.

  Subcategory: Beneficiary Engagement  

At a glance

IA_BE_25, Drug Cost Transparency, is a 2026 MIPS improvement activity in the Beneficiary Engagement subcategory, included in 3 MVPs. For PY2026 activities are not weighted: clinicians with small practice, rural, non-patient-facing, or HPSA status attest to one activity, all other Traditional MIPS participants attest to two, and MVP participants attest to one.

Activity description

Provide counseling to patients and/or their caregivers regarding: costs of medications using a real time benefit tool (RTBT) which provides to the prescriber real-time patient-specific formulary and benefit information for drugs, including cost-sharing for a beneficiary.

Activity details

• Activity ID: IA_BE_25
• Subcategory: Beneficiary Engagement
• Programs: Traditional MIPS, APP, APP Plus
• First performance year: 2020

MVPs that include this activity

Advancing Rheumatology Patient Care; Advancing Care for Heart Disease; Complete Ophthalmologic Care

Need help with IA_BE_25?

ReportingMD is a CMS qualified registry and healthcare data pipe with a 100% submission rate since 2001. We confirm IA attestations and documentation with every client before submission. Talk to a ReportingMD advisor or browse the full 2026 MIPS directory.